Jean Frazier to Psychotropic Drugs
This is a "connection" page, showing publications Jean Frazier has written about Psychotropic Drugs.
Connection Strength
0.585
-
Charlot LR, Hodge SM, Holland AL, Frazier JA. Psychiatric diagnostic dilemmas among people with intellectual and developmental disabilities. J Intellect Disabil Res. 2022 10; 66(10):805-816.
Score: 0.195
-
Frazier JA, Doyle R, Chiu S, Coyle JT. Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry. 2002 Jan; 159(1):13-21.
Score: 0.186
-
Cochran DM, Fallon D, Hill M, Frazier JA. The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry. 2013 Sep-Oct; 21(5):219-47.
Score: 0.105
-
Findling RL, Johnson JL, McClellan J, Frazier JA, Vitiello B, Hamer RM, Lieberman JA, Ritz L, McNamara NK, Lingler J, Hlastala S, Pierson L, Puglia M, Maloney AE, Kaufman EM, Noyes N, Sikich L. Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. J Am Acad Child Adolesc Psychiatry. 2010 Jun; 49(6):583-94; quiz 632.
Score: 0.083
-
Moore CM, Frazier JA, Glod CA, Breeze JL, Dieterich M, Finn CT, Frederick Bd, Renshaw PF. Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Am Acad Child Adolesc Psychiatry. 2007 Apr; 46(4):524-34.
Score: 0.017